Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
- Status
- RECRUITING
- Phase
- N/A
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.
- Status
- UNKNOWN
- Phase
- N/A
Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
- Status
- RECRUITING
- Phase
- PHASE2